The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from CNW Group

Atrium Innovations Acquires Robert & Fils - The Largest Distributor of Atrium Products in the Province of Quebec

Friday, April 15, 2011

Atrium Innovations Acquires Robert & Fils - The Largest Distributor of Atrium Products in the Province of Quebec11:55 EDT Friday, April 15, 2011Strategic acquisition of a longtime partner with an established sales forceQUEBEC CITY, April 15 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB), a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based natural health products for the health and nutrition industry, today announced the purchase of Montréal-based Robert & Fils, the largest distributor of Atrium's premium natural health products targeting healthcare practitioner (HCP) and health food and specialty store (HFS) channels in the province of Quebec."Robert & Fils and Atrium have been longtime partners," said Pierre Fitzgibbon, Atrium's President and CEO.  "We have been working together since Atrium's inception in 2000.  With the acquisition of Trophic and Seroyal brands in the past year, we expanded our Canadian footprint.  It was time for us to set up a strong platform in the province of Quebec.  This acquisition will provide us with market expertise and additional knowledge of the Quebec natural health product industry held by this experienced team.  In addition, close to 50% of Robert & Fils' revenues are comprised of certain Atrium products, providing us with a better control over our destiny in Quebec.""We will have the privilege of Mrs. Denise Poirier's presence as a consultant until the end of the year, providing us with full access to the deep industry knowledge she has built over the past 26 years while owning and operating the business."About AtriumAtrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products endorsed by health professionals. The Company distributes its extensive portfolio of products mainly in the healthcare practitioner and health food and specialized store channels, with a primary focus in North America and Europe. Atrium is at the forefront of science, innovation and education in the natural health products industry.  The Company has over 1,000 employees and operates seven manufacturing facilities.  Additional information is available at www.atrium-innovations.com.About Robert & FilsSince its foundation in 1937, Robert & Fils, a Canadian trendsetter in its field, has broadened its scope and continues to be at the forefront of the natural health industry. In addition to formulating its own supplements and therapeutic foods, Robert & Fils distributes several exclusive lines of premium quality, natural therapeutic products across the province of Quebec. Additional information about Robert & Fils is available on its website at www.robertetfils.com.Cautionary Note and Forward-Looking StatementsThis press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. These forward-looking statements, including financial outlooks, may involve, but are not limited to, comments with respect to the Company's business or financial objectives, its strategies or future actions, its targets, expectations for financial condition or outlook for operations and future contingent payments. Words such as "may", "will", "would", "could", "expect", "believe", "plan", "anticipate", "intend", "estimate", "continue", or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements.Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances.  The Company considers these assumptions to be reasonable based on information currently available to it, but cautions the reader that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its business.For additional information with respect to these and other factors and assumptions underlying the forward-looking statements made in this press release, see the Company's quarterly and annual Management Discussion and Analysis for the fiscal year ended December 31, 2010 filed with the Canadian securities commissions. The forward-looking information set forth herein reflects the Company's expectations as at the date of this press release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.For further information: Investor Relations:Mario Paradis  Vice President and Chief Financial Officer Tel.: 418 652-1116 mp@atrium-innovations.com Pierre Boucher MaisonBrison Tel.: 514 731-0000, ext. 237 pierre@maisonbrison.com Media Relations:Amélie Germain Director of Communications Tel.: 418 652-1116 ag@atrium-innovations.com